11Apr/13

Tamiflu sales boost Roche results despite efficacy concerns – PMLiVE


ABC News

Tamiflu sales boost Roche results despite efficacy concerns
PMLiVE
but there were solid gains for the firm’s blockbuster cancer drugs, with Herceptin (trastuzumab) and Avastin (bevacizumab) both rising 11 per cent to 1.57bn Swiss francs and 1.53bn Swiss francs respectively, and MabThera/Rituxan (rituximab) up 6
Roche sales rise thanks to oncology drugs and TamifluPharmaTimes
Roche 1st-qtr 2013 sales grow 6%, driven by cancer drugsThe Pharma Letter

all 23 news articles »

11Apr/13

Q&A: Organ Donation – BBC News

BBC NewsQ&A: Organ DonationBBC NewsThere has been a boom in organ donation in the UK according to figures by NHS Blood and Transplant. The number of people donating … Nearly a third of people in the UK, 20 million people, are on the NHS Organ Don…